Cargando…
Local Ablative Treatment Improves Survival in ESCC Patients With Specific Metastases, 2010–2016: A Population-Based SEER Analysis
BACKGROUND: We aimed to explore the role of local ablative treatment (LAT) in metastatic esophageal squamous cell cancer (ESCC) patients who received chemotherapy and identify patients who will most likely benefit. METHODS: We analyzed data of metastatic ESCC patients from the Surveillance, Epidemio...
Autores principales: | Yang, Hui, Wang, Kunlun, Li, Yan, Li, Shenglei, Yuan, Ling, Ge, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243329/ https://www.ncbi.nlm.nih.gov/pubmed/35785182 http://dx.doi.org/10.3389/fonc.2022.783752 |
Ejemplares similares
-
The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy
por: Yang, Hui, et al.
Publicado: (2021) -
Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016
por: Liu, Miao, et al.
Publicado: (2023) -
An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC
por: Yu, Hongliang, et al.
Publicado: (2021) -
Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER‐based study
por: Sun, Donglin, et al.
Publicado: (2022) -
The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
por: Yang, Hui, et al.
Publicado: (2020)